Unilever’s Cost Squeeze Meets Faster-Than-Expected Savings

Unilever beats Q1 forecasts with 3.8% organic revenue growth driven by volume, but faces €750-900M cost inflation; restructuring savings reach €750M ahead of schedule.

Unilever’s first-quarter results for 2026 tell a story of two opposing forces: robust volume-driven growth in emerging markets and a mounting cost inflation bill that threatens to erode margins. The Anglo-Dutch consumer goods giant is navigating this tension with a restructuring programme that is running well ahead of schedule, even as it prepares for a transformative shift in its business mix.

The company posted organic revenue growth of 3.8 percent for the opening quarter, edging past the 3.6 percent consensus forecast. More telling than the headline figure was the composition: volume contributed 2.9 percentage points, while pricing accounted for just 0.9 points. Analysts had expected a roughly equal split of 1.8 points each. That marks a strategic departure from recent years, when Unilever relied heavily on price hikes to sustain growth. The message from the numbers is clear — shoppers are buying more products, not just paying more for the same ones.

Unilever’s core Power Brands performed even better, with organic growth of 5.0 percent and volume expansion of 4.0 percent. Emerging markets provided the strongest tailwinds, with overall growth of 5.7 percent, of which 4.2 points came from volume. India accelerated to 7 percent growth, with a 6-point volume contribution. CFO Srinivas Phatak described the improvement as “broad-based,” driven by e-commerce and modern trade channels. Latin America returned to volume growth, with Brazil’s Home Care unit posting double-digit volume gains. China grew in the mid-single digits, while Indonesia expanded 4 percent on what Phatak called a more sustainable trajectory following a prior reset.

Yet the cost picture is darkening. Unilever now expects full-year cost inflation of between €750 million and €900 million. Roughly half of that burden falls on the Home Care division, and 70 percent of that is concentrated in emerging markets — precisely where growth is strongest. The company plans to respond with gradual, moderate price increases tailored by market and category. Products with high crude oil content in Home Care, along with markets in Asia, Africa and Latin America, will see the most adjustment.

The timing of the cost pressures is awkward, but Unilever’s internal efficiency drive is providing some relief. The company had originally targeted €800 million in savings by the end of 2026. It has already reached €750 million, putting the programme well ahead of plan. Those savings are helping to offset the inflation hit, though analysts remain divided on the net effect. Bank of America and Barclays both rate the stock a buy, though Barclays trimmed its price target to 4,950 pence. Kepler Capital and Berenberg are more cautious, with neutral ratings.

The bull case rests partly on valuation. Unilever’s shares trade at a forward price-to-earnings ratio of 15.4 for 2026, an 8 percent discount to European peers. Barclays argues the company is performing operationally better than many competitors. A key catalyst is the planned merger of Unilever’s food division with US spice maker McCormick, a deal valued at nearly $45 billion. Unilever will receive an upfront cash payment of $15.7 billion, which management intends to use for debt reduction, tax settlements and share buybacks. The transaction is expected to close by mid-2027, after which the company will incur one-off restructuring costs of €500 million.

Once the food unit is spun off, emerging markets will account for roughly 62 percent of Unilever’s remaining sales, underscoring the importance of those regions to the group’s future. The company has reaffirmed its full-year guidance, targeting organic revenue growth at the lower end of its 4 to 6 percent range, with volume growth of at least 2 percent. CEO Fernando Fernandez expressed confidence, citing a strong start to the second quarter and planned FIFA sponsorship activations in Personal Care.

The quarterly dividend has been raised to €0.4664 per share, a 3 percent increase year-on-year. A €1.5 billion share buyback programme has begun and is scheduled for completion by 6 July 2026. Separately, Unilever has agreed to acquire Grüns, a fast-growing US dietary supplements provider, for $1.2 billion.

Despite the positive first-quarter performance, the stock remains under pressure. It currently trades roughly 21 percent below its 52-week high of €63.08 and has lost more than 10 percent since the start of the year. Whether the strong Q1 numbers can shift sentiment will depend largely on how effectively Unilever manages the cost inflation headwinds in the second half.